Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society
Monika Nojszewska, Alicja Kalinowska-Łyszczarz, Monika Adamczyk‐Sowa, et al.
Neurologia i Neurochirurgia Polska (2021) Vol. 55, Iss. 1, pp. 8-11
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Administration of COVID-19 vaccines in immunocompromised patients
Manica Negahdaripour, Mojtaba Shafiekhani, Seyed Mohammad Iman Moezzi, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108021-108021
Open Access | Times Cited: 72
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases
Itay Lotan, Gabriela Romanow, Michael Levy
Multiple Sclerosis and Related Disorders (2021) Vol. 55, pp. 103189-103189
Open Access | Times Cited: 42
Nano-Microparticle Platforms in Developing Next-Generation Vaccines
Giuseppe Cappellano, Hugo Abreu, Chiara Casale, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 606-606
Open Access | Times Cited: 40
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein
Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 14-25
Open Access | Times Cited: 13
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations
Bülent Kantarcıoğlu, Omer Iqbal, Joseph M. Lewis, et al.
Clinical and Applied Thrombosis/Hemostasis (2022) Vol. 28
Open Access | Times Cited: 21
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
Agata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 763-763
Open Access | Times Cited: 13
Neurological Disorders following COVID-19 Vaccination
Ying Yang, Lisu Huang
Vaccines (2023) Vol. 11, Iss. 6, pp. 1114-1114
Open Access | Times Cited: 7
Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?
Shani Witman Tsur, Eli A Zaher, Meydan Tsur, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3859-3859
Open Access | Times Cited: 16
Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland
Agata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 10
Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland
Aleksandra Podlecka‐Piętowska, Janusz Sierdziński, Monika Nojszewska, et al.
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 1, pp. 112-119
Open Access | Times Cited: 1
Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic
Adam Stępień, Aleksandra Pogoda-Wesołowska, E Tokarz-Kupczyk, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 4, pp. 371-378
Open Access | Times Cited: 4
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Maura Pugliatti, Hans‐Peter Hartung, Celia Oreja‐Guevara, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Awareness of COVID-19 Symptoms, Risk Factors, and Vaccinations in Patients with Multiple Sclerosis
Ewa Krzystanek, Agata Jurczak, Kinga Kocur, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 6, pp. 3366-3366
Open Access | Times Cited: 4
Extremist language in anti-COVID-19 conspiracy discourse on Facebook
Karoline Marko
Critical Discourse Studies (2022) Vol. 21, Iss. 1, pp. 92-111
Closed Access | Times Cited: 4
Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians
Klara Dyczkowska, Alicja Kalinowska-Łyszczarz
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 90-100
Open Access | Times Cited: 2
SARS-CoV-2 and the nervous system
Alina Kułakowska
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 3-7
Open Access | Times Cited: 2
Recent Bibliometrics of the Journal and Thank You to Our Reviewers
Zbigniew K. Wszołek, Łukasz Stolarczyk, Jaroslaw Sławek
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 4, pp. 353-356
Open Access
Anti-severe acute respiratory syndrome coronavirus-2 antibody responses following Pfizer-BioNTech vaccination in a patient with multiple sclerosis treated with ocrelizumab: a case report
Hubert Mado, K Kubicka, Monika Adamczyk‐Sowa
Journal of International Medical Research (2021) Vol. 49, Iss. 9
Open Access | Times Cited: 4
RNAi-based pesticides: A magic bullet to deal with plant viruses
Chang Yoon Ji, Kyeong-Jae Heo, Rira Jeong, et al.
Elsevier eBooks (2023), pp. 525-555
Closed Access | Times Cited: 1
Latest bibliometrics of Polish Journal of Neurology and Neurosurgery
Zbigniew K. Wszołek, Łukasz Stolarczyk, Jaroslaw Sławek
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 4, pp. 329-331
Open Access | Times Cited: 1
Comment on the paper Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab: the likely explanation for this phenomenon based on our observations
Hubert Mado, Monika Adamczyk‐Sowa
Journal of Neurology (2021) Vol. 268, Iss. 11, pp. 3998-3999
Open Access | Times Cited: 3
COVID-19 infection and vaccination against COVID-19: Impact on managing demyelinating CNS disorders in Southern India- experience from a demyelinating disease registry.
Lekha Pandit, Amita Sudhir, Chaithra Malli, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 66, pp. 104033-104033
Open Access | Times Cited: 2
Immune response to COVID-19 vaccines in patients with multiple sclerosis treated with disease-modifying therapies
Waldemar Brola
Neurologia i Neurochirurgia Polska (2022) Vol. 57, Iss. 1, pp. 11-13
Open Access | Times Cited: 2
Rare post-vaccination complications: onset of relapsing-remitting multiple sclerosis after COVID-19 vaccination – case reports and literature review
Joanna Kyc, Halina Bartosik-Psujek
Aktualności Neurologiczne (2021) Vol. 21, Iss. 4, pp. 238-244
Open Access | Times Cited: 2
Vaccination in multiple sclerosis patients during the COVID-19 pandemic
Waldemar Brola, Ewa Bielecka
Aktualności Neurologiczne (2021) Vol. 21, Iss. 3, pp. 137-142
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top